StemCell Therapy

Pune, Sept. 29, 2020 (GLOBE NEWSWIRE) -- The global genomics market size is projected to reach USD 82.60 billion by the end of 2027. The massive investments in the research and development of efficient products will have a massive impact on the growth of the market in the coming years.

According to a report published by Fortune Business Insights, titled Genomics Market Size, Share & COVID-19 Impact Analysis, By Type (Products (Instruments & Software and Consumables) and Services), By Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Microarray, Sanger Sequencing, and Others), By Application (Diagnostics, Research, and Others), By End User (Research Institutes, Healthcare Facilities & Diagnostic Centers, Pharmaceutical & Biotechnological Companies, Contract Research Organization (CROs)), and Regional Forecast, 2020-2027, the market was worth USD 18.85 billion in 2019 and will exhibit a CAGR of 19.5% during the forecast period 2020-2027.

Genomics is a concept that involves the human gene and sequencing for treatment and study of several diseases or potential diseases. The study of human genetics helps identify and track critical diseases, with equal focus on the qualities and behaviour of a specific individual. In the past few years, genomics has contributed to the growth of numerous similar branches including the popular precision medicine.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/genomics-market-100941

The massive investments in the research and development of genomics and genomic sequencing will have a positive impact on the growth of the overall market in the coming years. The presence of several large scale companies has had a massive impact on the growth of the market in recent years and the influx of start-ups will create opportunities for growth in the foreseeable future.

Recent Clinical Studies have Indicated the Potential of Genomics to Tracking Patterns of Covid-19 Spread

The recent coronavirus outbreak has created a sense of panic among businesses across the world. Although healthcare industry has witnessed a contrasting impact, as compared to a few other sectors, there has been a recent surge in the need for healthcare professionals. The lack of skilled labour is consequential to the hesitancy among workers due to the severity of the disease. Although there are several ongoing research activities associated with the treatment of the coronavirus, there has been little success in this field.

Accounting to increasing cases of Covid-19 across the world, researchers are focusing on implementing preventive and precautionary measures through newer concepts. The excessive research associated with the use of genomics in Covid-19 pandemic has yielded a few successful measures. As a result, genomics has recently attracted attention from across the world.

The whole world is fighting the novel coronavirus. Sectors and industries are devasted due to the major loss caused by COVID-19 in business. The authorities of several countries have initiated lockdown to prevent the spread of this deadly virus. Such plans have caused disturbances in the production and supply chain. But, with time and resolution, we will be able to combat this stern time and get back to normality. Our well-revised reports will help companies to receive in-depth information about the present scenario of every market so that you can adopt the necessary strategies accordingly.

To get to know more about the short-term and long-term impacts of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/industry-reports/genomics-market-100941

Constant Product Innovations are Consequential to Increasing R&D Efforts

The report encompasses several factors that have contributed to the growth of the overall market in recent years. Among all factors, the increasing number of product innovations, driven by rising investments in the research and development of the product, has made the highest impact on the growth of the market. In April 2020, Eurofins announced the launch of a new product in the genome sequencing space.

The company introduced SARS-CoV 2 full length genome sequencing, a product that is categorized under the next-generation (NGS) sequencing category. Increasing number of such product innovations will have a positive impact on the growth of the overall market in the coming years.

North America to Emerge Dominant; Increasing Activities associated with Whole-genome Sequencing will Emerge in Favor of Market Growth

The report analyses the ongoing market trends across five major regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among all regions, the market in North America is projected to emerge dominant in the coming years. The increasing research activities associated with whole-genome sequencing by private companies as well as government organizations will contribute to the growth of the regional market.

As of 2019, the market in North America was worth USD 8.27 billion and this value is projected to rise at a considerable pace in the coming years. The market in Asia Pacific will derive growth form the efforts put in towards genetic sequencing by countries such as China.

Quick Buy - Genomics Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/100941

List of companies profiled in the Genomics Market report:

Industry Developments:

February 2020: Nebula Genomic announced the launch of a new product that will offer whole genome sequencing at US$ 299 to its customers.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/genomics-market-100941

Table of Contents:

TOC Continued.!

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/genomics-market-100941

Have a Look at Related Reports:

Next-Generation Sequencing (NGS) Market Share and Global Trend By Type (Products, Instruments & Software, Consumables, Services), By Application (Diagnostics, Research), By End User (Research Institutes, Healthcare Facilities & Diagnostic Centres, Pharmaceutical & Biotechnological Companies, Contract Research Organization) & Geography Forecast till 2026

Molecular Diagnostics Market Share and Global Trend By Product Type (Instruments Reagents & Consumables), Application (Infectious Disease, Blood Screening, Histology & Oncology), Technique (Hospitals Amplification, Hybridization & Sequencing Techniques), End User (Hospitals, Clinical & Pathology Labs) and Geography Forecast till 2025

Polymerase Chain Reaction (PCR) Market Share & Industry Analysis, By Type (Standard PCR, Real-time PCR, and Digital PCR), By Product (Instruments and Reagents & Consumables), By Indication (Infectious Diseases, Oncology, Genetic Disorders, and Others), By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Industries, Diagnostic Centers, and Academic & Research Organizations), and Regional Forecast, 2019-2026

Hormone Replacement Therapy (HRT) Market Share & Industry Analysis, By Therapy Type (Estrogen and Combinations Replacement Therapy, Growth Hormone Replacement Therapy, Thyroid Hormone Replacement Therapy), By Indication (Menopause, Hypothyroidism, Male Hypogonadism, and Growth Hormone Deficiency), By Route of Administration (Oral, Transdermal, and Parenteral), By Distribution Channel (Hospital Pharmacies), and Regional Forecast, 2019-2026

Heart Valves Market Share & Industry Analysis, By Product Type (Replacement (Aortic, Mitral, and Others), and Repair), By Valve Type (Tissue Valve and Mechanical Valve), By Procedure (Surgical and Transcatheter), By End User (Hospitals, and Specialty Clinics & Others), and Regional Forecast, 2019-2026

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India.

Phone:US :+1 424 253 0390UK : +44 2071 939123APAC : +91 744 740 1245Email: sales@fortunebusinessinsights.comFortune Business InsightsLinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/genomics-market-9172

See the rest here:
Genomics Market to Rise at 19.5% CAGR and Reach USD 82.60 Billion by 2027; Advances in Diagnostic Applications will Lead to a Wider Product Adoption,...

Best listening experience is on Chrome, Firefox or Safari. Subscribe to Federal Drives daily audio interviews onApple PodcastsorPodcastOne.

This topic can get emotional: Should animals be used in medical research? Now recently I aired an interview that was critical of the Veterans Health Administration for its use of cats in research experiments related to the bodily functions of paraplegics. VHAdid submit a rebuttal statement but the agency has not responded to requests for an interview. Americans for Medical Progress is an organization that advocates in favor of the ethical use of animals in medical research.Executive Director of Paula Clifford andCommunications Director Jim Newman joinedFederal Drive with Tom Temin.

Tom Temin:Alright, lets get right to this. Can animals be ethically used for research? We know they are, but is this something that has value in medical research?

Paula Clifford:Absolutely. I started out in research as a veterinary technician. And at that time, I was just doing an externship. I was a student, and I thought I would do my externship and go and spend my career working at a veterinary hospital. But during that time, I found that as a veterinary technician, I could dedicate my life to taking care of the animals that actually take care of people and other animals through research with them.

Jim Newman:And my early career experience was working at universities. I first worked at an institution in Oregon and then I worked for a cancer center. And what I learned from those experiences is that animals play a tremendously important role in developing treatments, I literally watched as cancer medications were developed, or new ways to treat patients were created through animal studies, or discovered through animal studies. And so thats one of the reasons I remain involved in this field is that I had first hand experience seeing the importance of this kind of research.

Tom Temin:And how is this done such that the animals dont suffer too much, in general?

Paula Clifford:Animals in research are cared for, a very large team of animal care professionals. And this is everybody from highly trained animal care technicians that do their day-to-day care. So feed, water, cleaning, and daily observations. And then you have veterinary technicians like me, who will then respond to any abnormal report. So if you have an itchy mouse, or a dog thats not eating normally, or a monkey thats behaving differently, that gets triaged to the vet care team. So the veterinary technician will check the animals out and then report that to the veterinarian who will come and diagnose and treat the animal.

Tom Temin:Well, let me ask you this, are there industry standards in the research community for how animals should be treated? Is there some sort of a certification program or any kind of inspection oversight that happens in facilities where animals are used in research?

Paula Clifford:Absolutely. So under the Animal Welfare Act, most animals are covered under that act. And that requires the USDA the United States Department of Agriculture to do at least an annual unannounced inspection to make sure that the animal care is compliant with those federal laws. But not all animals are covered under that act. But most animals are covered under the PHS policy, which needs to be followed by any institution that receives any government funding.

Tom Temin:PHS stands for ?

Paula Clifford:Public Health Service. So the majority of animals are covered under one of those two things. But there are some animals that are not and theres another layer, which is a voluntary accreditation by AAALAC International, and that really holds institutions at even higher standards. And they follow really detailed animal care protocols in a document called the guide for laboratory animal use.

Tom Temin:Jim, anything to add?

Jim Newman:I would just add that in addition to all of those external controls, there are internal controls at every institution, so as you probably can guess, there are inspections of facilities, and those are surprise inspections, but they cant be inspected every single day. So every institution is required to have its own system for monitoring how animals are cared for. And when you hear about something that happens, which is a rare thing that often is because the institution itself said, oh, heres an issue we need to address. So there are actually internal controls, as well as external controls to help ensure that animals are treated well.

Tom Temin:Were speaking with Jim Newman, hes the communications director, and with Paula Clifford, the executive director of Americans for Medical Progress. And again, you cant speak for what happens inside Veterans Affairs, but in your observations over the years, have the federal facilities that use animals in testing and there are quite a number of them generally follow these guidelines, including the federal ones?

Jim Newman:Absolutely. In fact, I was looking a little bit at the VAs research and it stands out for many reasons. One is that 99% of the research that the VA does is in rats and mice. Now you hear a lot of talk about other animals, and thats because the animal rights groups like to talk about that. But 99% is in, again, rats or mice, and in those very rare cases where they study other animals such as cats or dogs, theres a good reason for that its because those animals are specifically necessary for the kinds of studies that are conducted and looking at the list of achievements from the VA is pretty remarkable. Theyve been able to help veterans who receive spinal cord injuries that help them breathe, help them cough to clear their breathing channels. Bladder control is another issue that happens when you lose, you know, the ability to move your limbs. Thats something theyve helped them with. Artificial pancreas, organ transplants the list is 20 or 30 major items that have been accomplished through animal studies. So the VAs research is incredibly remarkable. Anybody who would like to do some research on it should really look at their site, because what theyre doing his outstanding research that actually helps both veterans but also all Americans.

Tom Temin:And Paula, what is it that your organization does to kind of get this word out? I mean, Americans for Medical Progress could cover almost any topic.

Paula Clifford:Sure. So a lot of what we do is we actually help those working with the animals either on the animal care side or the researcher side, to help them tell their story and share with the public really what its like to work with animals and research, why, when and how animals are involved in research. We also do a lot of work with institutions to help them engage with the public and really share, you know, what is it about animals that make it so necessary and so important to advance biomedical progress?

Tom Temin:I once spoke to a dairy farmer in a story I did is a very young reporter very many years ago. And they had, I dont know, 50 or 60 cows in this barn. And at the end of the cows life, I said, what happens when the cow gets too old? They said, well it becomes meat. I said, but dont you kind of get attached to them? They all have names hanging on their necks. And the farmer it was the wife of the farmer, I guess she was a farmer, too said, Well, we just consider it their final gift to us when they become steaks. And so not to get too touchy feely here, but people that handle animals in experimental situations, what kind of relationship do they have with the animals, do you think?

Paula Clifford:Oh, gosh, I can tell you what I know for sure. You certainly do get attached. I can share personal stories. And theres, if you talk to anybody who works with animals in research, they also do get attached. They have names. And often they do have to be euthanized at the end of the study. Because in order to get the data from the study, you need to look at the cellular level, you need to maybe take out the heart or look at the bladder. So thats really difficult. Any area of veterinary medicine can be heartbreaking, theres really rewarding and happy times. And theres really emotional and sad times. So theres crying that happens as well, because you do get attached to the animals and the end of study does come but we know that like the dairy farmer, it is their final gift to us. And not only will they be helping the scientists with their data, but the humans that will benefit from the data. And often the advancements that happen for humans also go on to benefit our pets as well: Surgical techniques, vaccines, medicines and multiple other types of advancements.

Tom Temin:And Jim, I guess people that are involved in this kind of work are also pet owners themselves, arent they?

Jim Newman:Thats very true. A lot of people enter animal care, for instance, because they want to work with animals, they want to be up close with them every single day. And you know, Americans, I think the percentage of Americans that own pets and love their pets is incredible. And of course, that includes scientists and animal care technicians. And anybody who works in a research facility. People who work with animals at work, also love those animals at work and at home. And theres some assumptions that people who work with animals in a research setting dont like animals, thats actually the opposite. The truth is that they love the animals they care for. And they probably go home to some of the pets that they also love just as much.

Paula Clifford:Yeah. And just to add, in some cases, when the study is complete, and the animal does not need to be euthanized, they get adopted. So I adopted a dog from research. He was on a pacemaker study, and he lived with us. I adopted him at seven and he lived with us until he at the end of his life of 15. So theres countless stories of researchers and animal care staff, veterinarians, veterinary technicians that adopt the animals that are able to be adopted when their study has ended.

Tom Temin:Paula Clifford is executive director of Americans for Medical Progress. Thanks so much for joining me.

Paula Clifford:It was a pleasure, thank you so much.

Tom Temin:And Jim Newman is the communications director. Jim, thank you.

Jim Newman:Thank you, sir.

Tom Temin:Well post this interview at FederalNewsNetwork.com/FederalDrive. Hear the Federal Drive on demand. Subscribe at Apple Podcasts or Podcastone.

Link:
Are there ethical ways to use animals in medical research? - Federal News Network

Nine members of the Texas A&M Veterinary Emergency Team (VET) and six agents from the Texas A&M AgriLife Extension Service will be deploying to Butte County, California on Saturday to help care for animals displaced by the ongoing wildfires.

The VET deployed to the same area last December to provide oversight on sheltering, inventory and data management, veterinary medical support for injured and ill animals, and efforts to reunite animals with their owners.

Our deployment to the camp wildfires in December 2018 and January 2019 set the stage for this request, said VET director Dr. Wesley Bissett. We have a close working relationship with the community we are being deployed to and our capabilities are well known to them.

Our primary role will be to provide consistency in operational management and veterinary medical care, he said. They have an outstanding group of people at the local level and I know we will all work together for the sake of the animals, their owners, and Butte County, California.

The teams mission will be to support three area shelters that have taken in almost 500 animals that have been displaced by the wildfires. The VET will bring their experience in managing emergency shelters and situations to help ease the stress being put on the local responders. The initial team deploying includes four veterinarians, two veterinary technicians, and three logistics and support personnel.

Anytime you go into out-of-state deployments, there is an element of uncertainty that is based on being so distant from the impact area, Bissett said. There is always a discovery phase during which you work to understand, specifically, what is needed so that your team can contribute to the success of the jurisdiction you are serving.

This isnt the first time this year that the VET has assisted with the ongoing wildfire efforts. Dr. Deb Zoran, VET member and professor in the Texas A&M College of Veterinary Medicine & Biomedical Sciences, recently deployed to Oregon to assist with the Texas A&M Task Force search and rescue dogs working in a particularly hazardous area.

For updates on the deployment, follow the VET on Facebook (@TAMUVET) and Twitter (@tamuvet1) and at tx.ag/VETteam.

Link:
Texas A&M VET Mobile Team Deploying To California To Assist With Wildfire Relief - Texas A&M University Today

Molly the Fire Safety Dog, one of the bigger names on Dog Twitter, could use some help with vet bills after a medical emergency this weekend.

Molly is an 8 year oldDalmatian from Clarksville, Arkansas who puts together livestreamed (and in-person when pawsible) demonstrations on fire safety for elementary students around the US and Canada through her Keep Kids Fire Safe Foundation.

While doing a livestream on her Facebook page on Saturday night, she possibly had a seizure or a stroke, which meant rushing over to an emergency animal hospital two hours away and an overnight stay.

Her blood pressure was checked out overnight, and she needed to visit an animal ophthalmologist (eye doctor specializing in medical care) on Sunday afternoon, which was a branch of veterinary medicine we didnt realize existed.

Im sitting outside hoping and praying the doc has good news, Mollys mom Dayna Hilton toldDog ODayon Sunday afternoon.

Becausevet bills are pricey at the best of times, and emergency procedures especially so, they would welcome PayPal donationsif you have the means to donate.

Everyone is so supportive and friendly, our palPeytonReads said earlier this year while talking about the kindness of Dog Twitter. Its more than positiveit is genuinely heartfelt care and concern. We gather and celebrate when someone is happy. We gather and offer support when someone is sad.

Molly was able to return home on Sunday night, and seemed exhausted but calm in a photo she shared.

Goodnight, everyone. Thanks for all the love and prayers you have sent my way, she wrote in the caption.

Molly was one of the recipients of the2019 ACE Awards(the American Kennel Clubs Award for Canine Excellence) in the Exemplary Companion Dog category, and she had a small role in the 2019 documentarySuperpower Dogs.Shes also the official ambassador ofSuperpower Dogs,and the mascot of the Keep Kids Fire Safe Foundation.

Close to home within the River Valley region of Arkansas, though, shes still the firedog for the local volunteer fire department, so she doesnt let the fame get to her head, even if she is friends with Bunsen the Science Dog and Sampson the Service Dog, not to mention an array of high-profile human members of Dog Twitter like Ive Pet That Dogs Gideonand Britishpet artist Iain Welch.

We hope Molly the Fire Safety Dog feels better soon, and that the kindness of the Dog Twitter community can help out with her vet bills.

Follow this link:
Molly the Fire Safety Dog needs help with vet bills after medical emergency - Dog of the Day

As a veterinarian, on a daily basis, were covering the grounds of treating and diagnosing medical conditions and also doing any surgeries that are required, also interacting with clientele, doing a lot of preventative care, a lot of puppy kitten work as well as older patients, so theres a wide variety in what you do every day, she says.

Cline has honed in her analytical side over the years, relying more on her intuition and experience, but its not just the animals suffering to worry about.

In the case of the hamster, Cline also mentions the bond that had formed between a young girl and the pet.

Theres that kind of unconditional love that they give you, they have needs and you provide for them; you get that positive feeling from that, and theyre just total affection, total love really, but a different kind than human love, she says of the bond between animals and humans.

For her, the two are inseparable.

I guess I love people and I love pets too. Veterinary medicine gives me that combination where I can interact with people in that capacity which I just love, she explains.

Truth be told, Cline isnt keen about her semi-retirement and talking about it makes her uncomfortable. But the pandemic has dramatically changed some of what she loves most about her job.

I like to practise in a very personal way, I like to focus on the client thats in (the room) and that pet and not be pressured or stressed or time restricted, she says. Its really hard to let go completely.

So, shes letting herself down slowly.

Shell miss her co-workers and the community work through the hospital raising awareness and funding for the Farley Foundation, which provides monetary support for those who struggle to pay for veterinary care.

Occupying her time isnt going to be a challenge. Between playing saxophone in two bands the Lincoln County Band & Jimmy Marando Swing Band gardening, and weekending at the cottage, she still plans on fitting in some time at the hospital.

At home, its an empty nest with John (her three boys are now grown and moved out) but shell be seeing more of her fur children an active Jack Russell terrier rescue and a former stray kitten, Tiger, who is now a grown 17-year-old.

While one door is slowly closing, another remains open in Clines heart should another animal be in need of the care and compassion that has, for so long, defined her work.

Its just about being able to serve, being able to provide. I think I really like to see a problem and solve the problem, she says.

Its just who she is.

View original post here:
'Really hard to let go': Grimsby veterinarian easing into retirement after 32 years - Niagarathisweek.com

Siyo, my name is Jessica Rose Lambert. I am the daughter of Kimlyn Sneed Lambert and the late Douglas Allen Lambert. I am from the Birdtown community, and a 2014 graduate of Cherokee High School and 2017 graduate of WCU. It has always been my life-long dream of mine to become a veterinarian. I am currently in my second year of attending post-graduate school at North Carolina State University in Raleigh, earning my Doctor of Veterinary Medicine Degree. It is my hope that one day I may be able to come back to the Qualla Boundary and open my own veterinary practice there. I would love to one day be able to help the people on the reservation with their pet care needs. I would also like to encourage EBCI students to consider becoming a Veterinarian, it is a great profession if you love animals like I do. I would like to personally thank the Yogi Crowe Scholarship for helping with my costs of living in Raleigh and for helping to make my dream a reality. They have generously provided funding that makes it possible for graduate students like me to make ends meet while attending school. Thank you again so very much!

Jessica Lambert

N.C. State Vet School Class of 2023

Original post:
THANK YOU: Lambert says thank you to Yogi Crowe Scholarship - The Cherokee One Feather - Cherokee One Feather

(Courtesy photo)

Kerry Sondgeroth, an associate professor and veterinary bacteriologist, accepted the position this month as the Riverbend Endowed Professor of Wildlife-Livestock Health at the University of Wyoming.

Sondgeroth, who comes from the Wyoming State veterinary laboratory, said the position has the potential to have an immense benefit on Wyomings livestock and wildlife.

She said she hopes the position will build a solid reputation at UW for wildlife-livestock health and bring awareness to the diseases being studied. Her appointment to the position is for five years.

Sondgeroth said the position can be a middle ground to gain understanding of certain diseases in order to protect the health of wildlife, livestock and humans.

Tim Mellon donated the Riverbend Ranch west of Laramie to the UW Foundation in 2011, with proceeds of the ranchs eventual sale earmarked to establish the endowment position in UWs College of Agriculture and Natural Resources.

Sondgeroth received her doctor of veterinary medicine degree from Colorado State University in 2006 and was a post-degree graduate student at Washington State University from 2006-13. She received a Ph.D. in veterinary science in 2013.

She said her training and position as the only veterinary bacteriologist in Wyoming provides exposure to many bacteriological diseases across the state of interest to livestock producers and wildlife interest groups.

Link:
Livestock, wildlife health focus of UW position Sheridan Media - Sheridan Media

r preparing for graduation will enter a marketplace rife with uncertainty. Still, there are plenty of careers that have shown fast growth in recent years and pay salaries of six figures or more.

Stacker breaks down 50 of these industries, the prerequisites for entering those fields, and how those jobs have been affected over the past year. We compiled a list of 50 fastest-growing jobs with average salaries of over $100,000 using 2019 data from the Bureau of Labor Statistics Employment Projections (released Sept. 1, 2020) and Occupational Employment Statistics (released March 31, 2020). The jobs are ranked by their 10-year projected employment change, and ties are broken by the projected employment in 2029. Any broad or vague groupings of jobs, as well as jobs that have "all other" in the name, were omitted from the list, as they do not reflect an accurate portrayal of one specific occupation.

The jobs listed in this article include transportation workers, judges and lawyers, and a bevy of STEM jobs (mathematicians, physics professors, and chemical engineers, to name a few). Different physicians and tech industry workers also make several appearances. Many of these professions necessitate postsecondary education or on-the-job training. Of course, more opportunities for lower-income citizens to gain access to these jobs are a growing concern for more Americans, as well as the need to invest in STEM education in communities that dont have the same resources as more affluent communities.

Click through to find out which fast-growing jobs might be of interest to you, a family member, or even a youngster you may know whos planning for the future, and be sure to check out Stackers other articles about the job market.

You may also like: Most popular college majors in America

The rest is here:
Fastest-growing jobs that pay over $100K | Your Money - jacksonprogress-argus

The past few months have proven to be challenging for almost everyone, and that includes pet owners who may be struggling to keep up with regular veterinary care for their animals.

It's not a stretch to understand that when the budget gets tight, pet vaccinations don't seem as essential as they once might have been.

Inspired in part by the fact that World Rabies Day is coming on Monday, acoalition of veterinary clinics and animal care providers in and around Seattle, in partnership with the WSU College of Veterinary Medicine, are holding the first-ever multi-site vaccination effort known as One Health Clinic.

This Saturday, September 26th from 1pm-4pm,they'll be helping low-income pet owners or people experiencing homelessnesswith access to pet food and veterinary care for their beloved animal companions.

As a post from Seattle Humane says: COVID-19 has made it harder for many folks to keep up with vet appointments, both due to financial hardship and accessibility issues. We are concerned about the number of Parvovirus cases being reported in the community. We will be offering the Parvo vaccine on Saturday during a multi-site vaccine clinic as part of World Rabies Day. We will be joined by several local shelters, nonprofits and government entities in offering these free clinics at five different locations from 1-4 p.m. Saturday.

The locations and the providers:

Health and safety is a key priority for these events, so strict adherence to mask-wearing, physical distancing, and hand sanitizing is expected.

Please help spread the word, as these organizationsaim to provide critical veterinary care to the animals who need it most during these unprecedented times.

See the rest here:
Free pet vaccinations offered this weekend in Seattle & around the Sound - Talk Radio 1210 WPHT

Twenty-Five Year Club: New Members for 2020

Since 1956, Penn has celebrated a rite of passage each year for faculty and staff who meet one common requisite: they have been members of the University community for 25 years. Another 163 new members crossed the 25-year mark in 2020. Although we wont be holding areception this year, we want to honor these employees and thank them for their commitment to Penn.

Division of Human Resources

N. Scott Adzick, Perelman School of MedicineDan Alig, Wharton SchoolJane Anderson, Perelman School of MedicineTerry Anderson, Perelman School of MedicineHaimanti Banerjee, Wharton SchoolBryant Barr, Facilities and Real Estate ServicesSarah Barr, Provost Interdisciplinary ProgramsJames Berger, Perelman School of MedicineEdward Bergman, Wharton SchoolHema Bhargava, Perelman School of MedicineAregawi Biru, Facilities and Real Estate ServicesEve Bosnick, School of NursingJennifer Bottomley, School of Arts and SciencesEric Bradlow, Wharton SchoolJoseph Breslin, School of Dental MedicineKathleen Brown, School of Arts and SciencesLoretta Brown, University LibraryBeverly Browne, Facilities and Real Estate ServicesRichard Cardona, Annenberg School for CommunicationMichele Carlin, Perelman School of MedicineLatanya Carter, Business ServicesJoseph Carver, Perelman School of MedicineLorene Cary, School of Arts and SciencesBenjamin Chang, Perelman School of MedicineYouhai Chen, Perelman School of MedicineArtur Cideciyan, Perelman School of MedicineJames Clavin, Division of FinanceTheresa Colligon, Perelman School of MedicineSherrie Cornish, Residential and Hospitality ServicesJulia Crane, School of Arts and SciencesBarbara Dallap Schaer, School of Veterinary MedicineAnnet Davis, Perelman School of MedicineCarmen De La Rosa, School of Arts and SciencesLeah Dennis, School of Arts and SciencesFrancis Deroos, Perelman School of MedicineMaiheng Dietrich, School of Arts and SciencesWinka Dubbeldam, Weitzman School of DesignMaryellen Eckenhoff, Perelman School of MedicineScott Edwards, Perelman School of MedicineRicardo Eiraldi, Perelman School of MedicineRonit Engel, School of Arts and SciencesStanford Ewing, Perelman School of MedicineAutumn Fiester, Perelman School of MedicineChioma Fitzgerald, Perelman School of MedicineJames Foskett, Perelman School of MedicineDouglas Fraker, Perelman School of MedicineRobert Gallop, Perelman School of MedicineArupa Ganguly, Perelman School of MedicineNoah Gans, Wharton SchoolJ. Gaynor, Perelman School of MedicineJames Gee, Perelman School of MedicineMaria Gifoli, Facilities and Real Estate ServicesCatherine Gontarek, Development and Alumni RelationsKathleen Hall, Graduate School of EducationJason Hart, Facilities and Real Estate ServicesGus Hartman, School of Arts and SciencesKaren Hirschman, School of NursingJoanne Inverso, Perelman School of MedicineSamuel Jacobson, Perelman School of MedicineStephanie Johnson, Perelman School of MedicineCynthia Johnson-Mollen, Perelman School of MedicineRandall Kamien, School of Arts and SciencesHillary Kane, School of Arts and SciencesAyako Kano, School of Arts and SciencesMarcelo Kazanietz, Perelman School of MedicineMary Kelly, Perelman School of MedicineDaniel Kessler, Perelman School of MedicinePeter Klein, Perelman School of MedicinePamela Knight, Wharton SchoolLaura Kosseim, Perelman School of MedicineVicky Kresge, Wharton SchoolPauline Kulynych, School of Arts and SciencesBarbara Lang, Perelman School of MedicineRobert Lawler, Information Systems and ComputingHae-Rhi Lee, Perelman School of MedicineJulie Leu, Perelman School of MedicineTrevor Lewis, General University SpecialJanet Lioy, Perelman School of MedicineGregg Lipschik, Perelman School of MedicineHuan Lou, School of Dental MedicinePing Loveland, Penn GlobalJohn Macdermott, School of Arts and SciencesRosemary Malague, School of Arts and SciencesRichard Maniglia, Perelman School of MedicineRichard Marcantuno, School of Veterinary MedicineMichael Marks, Perelman School of MedicineJerome Marrow, Facilities and Real Estate ServicesNicola Mason, School of Veterinary MedicineGiacomina Massaro-Giordano, Perelman School of MedicineDeborah Mathis, Student ServicesThomas Mccaffery, Information Systems and ComputingJoseph Mclaurin, Information Systems and ComputingJon Merz, Perelman School of MedicineStephen Metraux, Perelman School of MedicineBonnie Milas, Perelman School of MedicineJaime Miller, School of Veterinary MedicineClaire Mitchell, School of Dental MedicineFrank Moore, Facilities and Real Estate ServicesDiedre Morrison, Division of Public SafetyAnn Moyer, School of Arts and SciencesMary Mullins, Perelman School of MedicineDavid Musto, Wharton SchoolAnn OBrien Jenkins, Perelman School of MedicineKim Olthoff, Perelman School of MedicineOlga Ortiz, Perelman School of MedicineAnthony Pagano, Facilities and Real Estate ServicesFelicity Paxton, Annenberg School for CommunicationLouise Pedraz, Human ResourcesMartha Penny, Perelman School of MedicineAnn Perch, Wharton SchoolMichael Perillo, School of Dental MedicineJeanmarie Perrone, Perelman School of MedicineChristopher Petro, Perelman School of MedicineRebecca Phillips, School of NursingLoretta Picklo, Facilities and Real Estate ServicesDonald Pijak, Perelman School of MedicineMary Pipan, Perelman School of MedicineAnne Pomerantz, Graduate School of EducationJ.Russell Ramsay, Perelman School of MedicineTarik Richardson, Wharton SchoolMary Ritchie, Information Systems and ComputingLouis Rulli, Law SchoolPaul Ryersbach, University LibraryBernadette Salera, Perelman School of MedicineMohnednur Salih, Business ServicesBarbara Savage, School of Arts and SciencesSusan Schachtner, Perelman School of MedicineTheresa Schuck, Perelman School of MedicineJonathan Schug, Perelman School of MedicineStacey Secreto-Dankanich, School of Dental MedicineAbraham Shaked, Perelman School of MedicineAllen Shinn, Perelman School of MedicineDouglas Sloane, School of NursingPam Smith, Perelman School of MedicineWenchao Song, Perelman School of MedicineShobana Sood, Perelman School of MedicineMichele Souli, School of Arts and SciencesLaura Sprague, School of Dental MedicineSusan Staggs, Provosts CenterHolly Stefanow, Perelman School of MedicinePaul Stephens, Perelman School of MedicineAlan Strudler, Wharton SchoolTomoko Takami, School of Arts and SciencesJian-Qin Tao, Perelman School of MedicineGihan Tennekoon, Perelman School of MedicineJoanne Thorvaldsen, Perelman School of MedicineDavid Toccafondi, University LibraryDonald Tsai, Perelman School of MedicineGregory Van Duyne, Perelman School of MedicineAntonia Villarruel, School of NursingKevin Walker, School of Arts and SciencesDonna Walter, Facilities and Real Estate ServicesAnn Webb, Development and Alumni RelationsFrederick Webb, Facilities and Real Estate ServicesJanet Weiner, Perelman School of MedicineTimothy Wells, University LibraryE. Wileyto, Perelman School of MedicineYin Wong, School of Social Policy and PracticeBarbara Woodford, School of Arts and SciencesYanjie Yi, Perelman School of MedicineXiuqin Zhou, University MuseumHongming Zhuang, Perelman School of MedicineEmily Zug, School of Veterinary Medicine

See the original post:
Twenty-Five Year Club: New Members for 2020 | University of Pennsylvania Almanac - UPENN Almanac

A veterinary is related to diseases, injuries and treatment of farm, domestic or wild animals. Veterinary industry is mainly because of increased pet ownership, awareness of animal health issues, demand for animal related products and the availability of advanced surgical and diagnostic procedures. There are various technologies involved in veterinary medicine. Nowadays, animal health product such as metabolic drugs, anti-infective, reproductive aids, feed additives, vaccines, imaging diagnostics, topical solutions and parasite controls are becoming more popular.

Market Research Engine has published a new report titled as Veterinary Weighing Platforms Market Size By Application (Veterinary Hospitals, Veterinary Clinics, Home Use), By Type (With Digital Display, Separate Indicator), By Region (North America, Europe, Asia-Pacific, Rest of the World), Market Analysis Report, Forecast 2018-2024.

Browse Full Report: https://www.marketresearchengine.com/veterinary-weighing-platforms-market

In animal hospitals and clinics, the doctors treat injuries and disease of animals, but get most of the revenue from animal health procedures such as neutering and spaying, vaccinations, and regular checkups. Veterinary Weighing Scale is used to weigh pets weight for correct dosage of medicine and also to check healthy growth.

Market Insights

The global Veterinary Weighing Platforms market is segregated on the basis of Application as Veterinary Hospitals, Veterinary Clinics, and Home Use. Based on Type the global Veterinary Weighing Platforms market is segmented in With Digital Display and Separate Indicator.

The global Veterinary Weighing Platforms market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Veterinary Weighing Platforms market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

Competitive Rivalry

Befour, Inc, Bosche GmbH & Co.KG, Detecto Scale, DRE Veterinary, Horse Weigh, KERN & SOHN, Leading Edge, Marsden Weighing Machine Group, Shor-Line, SR Instruments, and others are among the major players in the global Veterinary Weighing Platforms market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

The Veterinary Weighing Platforms Market has been segmented as below:

Veterinary Weighing Platforms Market, By Application

Veterinary Weighing Platforms Market, By Type

Veterinary Weighing Platforms Market, By Region

Veterinary Weighing Platforms Market, By Company

The report covers:

Report Scope:

The global Veterinary Weighing Platforms market report scope includes detailed study covering underlying factors influencing the industry trends.

The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.

The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Veterinary Weighing Platforms market share. Major industry players with significant revenue share include Befour, Inc, Bosche GmbH & Co.KG, Detecto Scale, DRE Veterinary, Horse Weigh, KERN & SOHN, Leading Edge, Marsden Weighing Machine Group, Shor-Line, SR Instruments, and others.

Reasons to Buy this Report:

Request Sample Report from here: https://www.marketresearchengine.com/veterinary-weighing-platforms-market

Table of Contents:

Other Related Market Research Reports:

Electronic Veterinary Weighing Scale Market 2019|Top Key Players Analysis, Trends, Global Size Forecast To 2024

About MarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: [emailprotected]

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/

Read the original here:
Veterinary Weighing Platforms Market Size, Share 2020 Growth Analysis, Share, Demand By Regions, Types And Analysis Of Key Players- Research Forecasts...

September 24, 2020, 11:10 PM

4 min read

They say you can't teach an old dog new tricks, but trainers in Finland claim 8-year-old greyhound mix Kssi learned to identify a scent associated with COVID-19 in just seven minutes.

Helsinki Airport welcomed Kssi and nine other "coronavirus-sniffing dogs" as part of a pilot program this week meant to "speed up the process of identifying those infected with COVID-19."

Trainer Susanna Paavilainen is seen with Kossi (L) and Miina, sniffer dogs being trained to detect COVID-19 from the arriving passengers' samples, at Helsinki Airport in Vantaa, Finland, Sept. 22, 2020.

"We are among the pioneers," Helsniki Airport director Ulla Lettijeff said. "As far as we know, no other airport has attempted to use canine scent detection on such a large scale against COVID-19."

Four dogs will work at the airport during a shift, but passengers getting tested will not have direct contact with the dogs.

They will be prompted to swipe their skin with a wipe and drop it into a cup, which is then given to the dog to smell.

"The service is mainly intended for passengers arriving from outside the country," Susanna Paavilainen, CEO of WiseNose Ry, University of Helsinki's DogRisk research, explained.

Kossi, one of the sniffer dogs being trained to detect COVID-19 from the arriving passengers' samples, is seen at Helsinki Airport in Vantaa, Finland, Sept. 22, 2020.

The airport said that according to preliminary tests conducted by a research group at the Faculty of Veterinary Medicine at the University of Helsinki, "dogs are able to smell the virus with almost 100% certainty."

In the U.S., testing is still underway to determine if dogs can truly sniff out the coronavirus. The University of Pennsylvania's School of Veterinary Medicine (Penn Vet) launched a pilot study in April that would take a group of dogs and expose them to COVID-19-positive saliva and urine samples in a laboratory setting.

Once the dogs learned the odor, investigators would then see whether or not the animals can discriminate between COVID-19 positive and negative samples in a lab setting, according to Penn Vet.

While the results of the study have not yet been released, Penn Vet called it "pioneering" saying it "sets the stage for dogs to be a force multiplier in the mission to detect COVID-19, particularly among asymptomatic patients, or hospital or business environments where testing is most challenging."

Both the Transportation Security Administration (TSA) and U.S. Customs and Border Protection (CBP) told ABC News they are not training their canines to detect COVID-19.

See the original post here:
COVID-19 canines: How dogs may help sniff out the coronavirus in humans - ABC News

Latest research report, titled Global Genomic Biomarker Market Insights, Forecast to 2025. this report included a special section on the Impact of COVID-19. Also, Genomic Biomarker Market (By major Key Players, By Types, By Applications, and Leading Regions) Segments outlook, Business assessment, Competition scenario and Trends .The report also gives 360-degree overview of the competitive landscape of the industries. SWOT analysis has been used to understand the strength, weaknesses, opportunities, and threats in front of the businesses. Moreover, it offers highly accurate estimations on the CAGR, market share, and market size of key regions and countries. Players can use this study to explore untapped Genomic Biomarker markets to extend their reach and create sales opportunities.

Top Key players profiled in the report include:Bio-Rad, Beckman Coulter, Myriad Genetics, Thermo Fisher Scientific, Roche, QIAGEN, Epigenomics, Almac, Pfizer, Human Longevity, ValiRx, Personalis, Eagle Genomics, Empire Genomics, Agilent, Illumina and More

To Get PDF Sample Copy of the Report(with covid 19 Impact Analysis): https://www.globmarketreports.com/request-sample/4134

Genomic Biomarker market competitive landscape offers data information and details by companies. Its provides a complete analysis and precise statistics on revenue by the major players participants for the period 2020-2025. The report also illustrates minute details in the Genomic Biomarker market governing micro and macroeconomic factors that seem to have a dominant and long-term impact, directing the course of popular trends in the global Genomic Biomarker market.

Market Segment By Type:OncologyCardiologyNeurologyNephrology

Market Segment By Application:HospitalsDiagnostic and research laboratories

Regions Covered in the Global Genomic Biomarker Market: The Middle East and Africa (GCC Countries and Egypt) North America (the United States, Mexico, and Canada) South America (Brazil etc.) Europe (Turkey, Germany, Russia UK, Italy, France, etc.) Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Years Considered to Estimate the Market Size:History Year: 2015-2019Base Year: 2019Estimated Year: 2020Forecast Year: 2020-2025

Get Chance of up to 30% Extra Discount @ https://www.globmarketreports.com/request-discount/4134

Some Major TOC Points:

For More Information with including full TOC: https://www.globmarketreports.com/industry-reports/4134/Genomic-Biomarker-market

Customization of the Report:Glob Market Reports provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Get Customization of the [emailprotected]:https://www.globmarketreports.com/report/request-customization/4134/Genomic-Biomarker-market

Get in Touch with Us :Mr. Marcus KelCall: +1 915 229 3004 (U.S)+44 7452 242832 (U.K)Email: [emailprotected]

See the original post:
Genomic Biomarker Market 2020 | Know the Latest COVID19 Impact Analysis And Strategies of Key Players: Bio-Rad, Beckman Coulter, Myriad Genetics,...

In this report, we analyze the Precision Medicine Software industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2014 to 2019. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2014 to 2019. We also make a prediction of its production and consumption in coming 2019-2024.

Request sample copy athttps://www.reportsintellect.com/sample-request/1055238?utm_source=apsters&utm_medium=24

At the same time, we classify different Precision Medicine Software based on their definitions. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What is more, the Precision Medicine Software industry development trends and marketing channels are analyzed.Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

Key players in global Precision Medicine Software market include:SyapseAllscriptsQiagenRoper TechnologiesFabric GenomicsFoundation MedicineSophia GeneticsPierianDxHuman LongevityTranslational SoftwareGene42, IncLifeomic Health

Inquire for a Discount at https://www.reportsintellect.com/discount-request/1055238?utm_source=apsters&utm_medium=24

Market segmentation, by product types:Cloud-basedOn-premise

Market segmentation, by applications:Healthcare ProvidersPharmaceutical and Biotechnology CompaniesResearch Centers and Government InstitutesOthers

Market segmentation, by regions:North AmericaEuropeAsia PacificMiddle East & AfricaLatin America

The report can answer the following questions:1. What is the global (North America, South America, Europe, Africa, Middle East, Asia, China, Japan) production, production value, consumption, consumption value, import and export of Precision Medicine Software?2. Who are the global key manufacturers of Precision Medicine Software industry? How are their operating situation (capacity, production, price, cost, gross and revenue)?3. What are the types and applications of Precision Medicine Software? What is the market share of each type and application?4. What are the upstream raw materials and manufacturing equipment of Precision Medicine Software? What is the manufacturing process of Precision Medicine Software?5. Economic impact on Precision Medicine Software industry and development trend of Precision Medicine Software industry.6. What will the Precision Medicine Software market size and the growth rate be in 2024?7. What are the key factors driving the global Precision Medicine Software industry?8. What are the key market trends impacting the growth of the Precision Medicine Software market?9. What are the Precision Medicine Software market challenges to market growth?10. What are the Precision Medicine Software market opportunities and threats faced by the vendors in the global Precision Medicine Software market?

Objective of Studies:1. To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global Precision Medicine Software market.2. To provide insights about factors affecting the market growth. To analyze the Precision Medicine Software market based on various factors- price analysis, supply chain analysis, Porte five force analysis etc.3. To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, Latin America and Rest of the World.4. To provide country level analysis of the market with respect to the current market size and future prospective.5. To provide country level analysis of the market for segment by application, product type and sub-segments.6. To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.7. To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Precision Medicine Software market.

About Us:-

Reports Intellect provides Research Reports for everything related to market research and market intelligence. We are aware of trade importance and market need in todays competitive world.

Our team works efficiently to fetch the most authentic research reports backed with perfect data figures that guarantee outstanding results every time for you and your business.

Whether it is the latest report from the researchers or a custom demand feel free to contact us. We are available 24 hours for our beloved clients.

Contact Us:

[emailprotected]

PH + 1-706-996-2486

Read more here:
Precision Medicine Software Market by Trends, Dynamic Innovation in Technology and 2025 Forecasts | Covid-19 Analysis - The Daily Chronicle

Hair loss can be the result of complex environmental and genetic processes. In the former camp lies responses to stressful situations and certain cancer treatments. In the genetic camp is androgenetic alopecia - commonly known as pattern baldness. It usually runs in the family, which, on the face of it, seems dispiriting.

Fighting genetics may seem like a losing battle but evidence does suggest you can reverse this form of hair loss.

One strategy that has yielded surprising results is applying a melatonin solution to the scalp.

Most people will associate melatonin with sleep - the hormone plays a central role in the bodys sleep-wake cycle.

As the National Sleep Foundation explains, its production increases with evening darkness, promoting healthy sleep and helping to orient our circadian rhythm.

READ MORE:Hair loss treatment - Dr Sara explains the best type of shampoo to stimulate hair growth

Circadian rhythms are 24-hour cycles that are part of the bodys internal clock, governing important processes such as the sleep-wake cycle.

Theres evidence that the benefits of melatonin extend to treating hair loss.

This is because melatonin also affects hair growth, as the hair growth cycle in mammals is under circadian control, according to The Lifespan Research Institute, a research body that focuses on anti-ageing compounds.

"As with other circadian cycles, the hair growth cycle becomes dysregulated and lower in amplitude with age," explains the research body.

DON'T MISSThe breakfast food that could stimulate hair growth and lower your risk of hair loss[INSIGHT]How to live longer: A juice to fight against cancer, reduce wrinkles and boost longevity[TIPS]Four of the most common early warning signs of vascular dementia[INSIGHT]

In a randomised double-blind study of 40 women with hair loss, melatonin solution applied to the scalp increased hair growth significantly relative to placebo.

What's more, in a study published in the International journal of trichology, 1891 male and female patients with androgenic alopecia applied a topical melatonin solution for three months.

At three months 61 percent of patients had no hair loss, compared to 12.2 percent at the start; 22 percent had new hair growth at three months compared to four percent at baseline.

The incidence of seborrheic dermatitis also declined, from 34.5 percent at baseline to 9.9 percent at three months.

Seborrheic (seb-o-REE-ik) dermatitis is a common skin condition that mainly affects your scalp.

The skin condition can cause an itchy, flaky rash, which may lead to hair loss due to excessive itching.

According to the NHS, finasteride and minoxidil are the main treatments for male pattern baldness.

"Minoxidil can also be used to treat female pattern baldness. Women shouldn't use finasteride," explains the NHS.

There are a number of drawbacks to consider before taking these treatments.

According to the NHS, these treatments:

These treatments:

Alternatively, some wigs are available on the NHS, but you may have to pay unless you qualify for financial help.

While considering your options, you may benefit from some psychological support.

Your GP may be able to help you get some counselling or you can join a support group, adds the NHS.

See the original post:
Losing hair fast? Applying this natural solution to the scalp resulted in new hair growth - Express

Two recent studies by a UB researcher could help increase safety and minimize expense for patients undergoing glaucoma surgery.

The studies were conducted over several years by Asher Weiner, clinical associate professor in the Department of Ophthalmology in the Jacobs School of Medicine and Biomedical Sciences at UB. Weiner is affiliated with UBMD Ophthalmology at the Ross Eye Institute.

Glaucoma is one of the leading causes of blindness in people over the age of 60. It is a progressive condition in which the optic nerve, which is vital for vision, is damaged, often by abnormally high pressure in the eye (intraocular pressure, or IOP). This high pressure occurs when there is a buildup of fluid (aqueous humor) inside the eye, and in order to prevent blindness from glaucoma, IOP must be reduced to a safe level.

The first study was published in the Journal of Glaucoma in May. This retrospective, interventional research was conducted in a private glaucoma and cataract practice in Albany, New York, between 2014 and 2016. Weiner was affiliated with St. Peters Hospital in Albany at that time. He moved to Buffalo in 2017.

In this study, researchers sought to compare the safety and success rate of two different types of minimally invasive glaucoma surgery, or MIGS.

Instead of creating or implanting artificial drainage systems into the eye to reduce IOP procedures with increased intra- and postoperative risk most MIGS procedures utilize and enhance the eyes natural drainage system, increasing the drainage out of the eye and thereby reducing IOP.

The eyes drainage system is naturally restricted by the trabecular meshwork, the so-called strainer in the sink, Weiner says. Most MIGS procedures either remove a significant portion of this natural barrier, or bypass it using a tiny stent.

Weiner conducted the first MIGS in Michigan 12 years ago. Since then, as the success of MIGS has been demonstrated and confirmed, manufacturers have begun to develop devices to insert through the trabecular meshwork to achieve better flow out of the natural drain. There is a significant cost difference among different types of MIGS, ranging from $300-$650 with no implanted stent, to $1,750 with a stent.

In this study, Weiner compared two different types of MIGS with and without a stent over several years to also determine if the extra cost is justified for the patient and to the health care system.

He compared the surgical outcomes in patients who had two different types of MIGS in their eyes one that included implanting a stent in one eye, and one without a stent in the other eye. The objective, he says, was to examine whether the outcomes are the same, and whether a higher expense is justified.

The research found that the original method, without implanting the stent, does a better job than the stent, he says.

The bottom line is that the expensive device was less effective than the more economical original method, he says.

The second study was published online ahead of print in July in the journal Ophthalmology Glaucoma. Like the earlier research, it was a retrospective, interventional study conducted in Weiners Albany private practice between 2014 and 2016.

When lower-risk surgeries such as MIGS are insufficient to protect the optic nerve from progressive glaucoma damage, tube shunt implantation is a more effective method to reduce intraocular pressure to a safer level. However, this more aggressive procedure could increase intra- and postoperative risks.

According to the American Academy of Ophthalmology, the principal postoperative risk following tube shunt implantation into the anterior chamber of the eye (the location in the eye where tubes have traditionally been placed) is corneal decompensation and failure, leading to loss of vision and a need for corneal transplantation in an attempt to restore vision.

Thus, Weiner explains, the drawback to implanting tubes into the anterior chamber of the eye is that the tube is placed too close to the cornea, leading to corneal endothelial cell damage and corneal failure over time.

The alternative method is to insert the tube shunt behind the iris through an area called the ciliary sulcus instead of into the anterior chamber, thereby hiding the tubes behind the iris far enough from the cornea to prevent corneal damage and long-term visual loss.

Weiner has been working to further develop this surgical method for the past 12 years, and has presented his results through multiple publications and presentations.

In this study, the authors compared the rate of decline in corneal endothelial cell density following sulcus tube shunt implantation. The research showed that the rate of cell loss following sulcus tubes was a non-statistically significant 8% over two years, compared to a statistically significant loss of 20% to 30% following tubes implanted into the anterior chamber.

There was still loss, but not as dire when the tube shunt was inserted through the sulcus, and none of our patients demonstrated clinical corneal damage, Weiner says. This was the first time this was demonstrated.

The researchers also measured cell loss in eyes with glaucoma that were not being treated with shunts. Those eyes also showed cell loss (3%) over the two-year period, Weiner says.

Our findings strengthen the argument for how tube shunts should be implanted to protect our patients long-term vision, he says. But since our surgical methods require a higher skill level and may require a slightly longer operative time, many surgeons still prefer the old method.

However, in recent years, researchers have seen greater conversion to sulcus tubes around the world, he adds.

Co-authors on both studies include Weiners sons, Adam J. Weiner and Yotam Weiner from Beaumont Hospital, Oakland University William Beaumont School of Medicine in Royal Oak, Michigan.

Read the rest here:
Comparisons of glaucoma surgeries show certain techniques are safer, more effective - UB Now: News and views for UB faculty and staff - University at...

The Food and Drug Administration continues to add hand sanitizers to a list of products that should be avoided, with the list climbing to 196.

Many of the recalled products contain methanol or 1-propanol, which are very dangerous. Only ethyl alcohol and isopropyl alcohol (also known as 2-propanol) are acceptable types of alcohol in hand sanitizer, according to the FDA.

The complete list can befound on the FDAs site.

FDA test results also showed some hand sanitizers had much lower levels of active ingredient than listed on the label. The CDC recommends alcohol-based hand sanitizers have at least 60% ethyl alcohol (sometimes listed as alcohol on the label).

Other products were found with false or misleading claims on labels, including false claims that the brand prevents the spread of COVID-19 or protects you from viruses or bacteria for a certain period of time.

Methanol, or methyl alcohol, is used to make rocket fuel and antifreeze and should never be rubbed on your skin or swallowed. Swallowing or drinking hand sanitizers contaminated with methanol can cause serious health problems, including permanent blindness, and death, according to the FDA.

1-Propanol or 1-propyl alcohol is used to make industrial solvents and can also be toxic when swallowed. Swallowing or drinking a hand sanitizer with 1-propanol can result in decreased breathing and heart rate, among other serious symptoms, and can lead to death, the FDA says.Symptoms of exposure can include confusion, decreased consciousness and slowed pulse and breathing.

The FDA also says hand sanitizer should never be used on pets. If your pet gets hand sanitizer on their skin or accidentally ingests it (such as by chewing the bottle), the FDA says to contact your veterinarian or an animal poison control service immediately.

Read this article:
More products added to FDA hand sanitizer recall list - FOX40

Angela Elam

(PRESS RELEASE) CHICAGO Fight for Sight, the first nonprofit organization in the United States to promote eye research, and Prevent Blindness, the nations oldest voluntary eye health organization, announced the recipient of the 2020 Joanne Angle Public Health Award as Angela R. Elam, MD, Clinical Assistant Professor, Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan. The $25,000 grant was awarded for Dr. Elams study, Engagement in Telemedicine-based Glaucoma Screening in the Community Clinics.

The Joanne Angle Public Health Award is presented annually to research focusing on the public health side of vision and eye health. It was named for Ms. Joanne Angle who served on the National Board of Directors for Prevent Blindness, and both its Government Affairs and Audit committees, in addition to her work with the Association for Research in Vision and Ophthalmology (ARVO). Glaucoma is a group of eye conditions that damage the optic nerve, often caused by an abnormally high pressure in the eye. Those with glaucoma usually start losing their side (peripheral) vision. According to the Prevent Blindness report, The Future of Vision: Forecasting the Prevalence and Costs of Vision Problems, there are more than 3.2 million older adults in America with glaucoma. The total number is expected to increase rapidly as the U.S. population ages. Minority populations will also increasingly be affected.

The purpose of the Engagement in Telemedicine-based Glaucoma Screening in the Community Clinics study is to identify innovative strategies to better engage populations of people most at risk of vision loss from glaucoma and who are least likely to have access to an eye care provider in glaucoma screening and treatment. Both poverty and being of minority background lead to a higher risk of having glaucoma, and not getting adequate specialty treatment for glaucoma.

Dr. Elam is leading her team in implementing a telemedicine-based glaucoma screening program in two free clinics to overcome many of the logistical and psychosocial barriers to glaucoma screening. Interviews will be conducted of clinic staff, patients, and those accessing non-medical services to identify the best ways to engage community participants in the glaucoma screening program.

Telemedicine is truly making a tremendous impact in providing essential services to those who do not have the access they need to stay healthy, said Jeff Todd, president and CEO of Prevent Blindness. We are proud to give Dr. Angela Elam and her team this years Joanne Angle Public Health Award that provides funding that helps to save sight in those at highest risk for vision loss from glaucoma.

Fight for Sight is glad to partner with Prevent Blindness and congratulates Dr. Elam and her team on this award, said Michael Brogioli, executive director of Fight for Sight. Their work to engage underserved communities is especially critical during this extraordinary time.

Past recipients of the Prevent Blindness Joanne Angle Award include Brian J. Song, MD, MPH, at the Massachusetts Eye and Ear, and the Department of Ophthalmology at Harvard Medical School, for his study Glaucoma Detection in Diabetes Teleretinal Programs, and Rajeev S. Ramchandran, MD, MBA, Associate Professor of Ophthalmology, University of Rochester School of Medicine and Dentistry, for his study, Implementation Science Based Study of Teleophthalmology for Diabetic Retinopathy Surveillance.

For more information on the Fight for Sight-Prevent Blindness Joanne Angle Public Health Award, please contact Jean Song, Fight for Sight, at [emailprotected].

Read more here:
Fight for Sight and Prevent Blindness Announce Recipient of the 2020 Joanne Angle Public Health Award - InvisionMag

Why Global Citizens Should Care

When William Tasiame saw a young boy infected with rabies, he knew the child was going to die.

"He gasped for breath, hiding his face from the light. I knew the symptoms from dogs, they are similar. It is a sad death and it was the worst thing I have seen in my life," Tasiame told Global Citizen.

Tasiame studied veterinary medicine in Cuba, before going back to his home country of Ghana, where he worked as a veterinarian for 12 years. Today, he is doing research for his doctoral thesis on rabies under Christian Drosten at the Charit in Berlin, Germany.

Although rabies had always been an interest in Tasiames professional life, it wasnt until he saw that child suffering from it with his own eyes that he decided he would dedicate his research and all his energy to fighting it.

Once a person begins to show signs of having rabies, it will almost always lead to death. Signs and symptoms include headaches, nausea, vomiting, abdominal pain, diarrhea, fever, or cough. But they also include confusion, difficulty swallowing, hallucinations, and a fear of water, according to the Centers for Disease Control and Prevention (CDC).

Rabies is almost always transmitted by infected animals, mostly dogs or wild animals, such as foxes, bats, and raccoons. The virus travels through the nerves to the spinal cord and brain. It usually takes three to eight weeks between initial contact with the virus and the onset of symptoms.

"Rabies is a very brutal disease that mainly affects children and there is nothing you can do about it. There are no active ingredients or medication to combat it. Once the brain is affected, it's too late," Tabea Binger, laboratory manager of the Kumasi Center for Collaborative Research, a research facility of the Bernhard Nocht Institute for Tropical Medicine in Ghana, told Global Citizen.

Like Tasiame, Binger also wrote her doctoral thesis under Christian Drosten. She focused on viruses that infect bats and that can be transmitted to humans one of which is the rabies virus.

Having studied the virus so intensively, Binger explained that she has been vaccinated against rabies and that every year, she was tested to ensure that the protection provided by the vaccine was still sufficient.

"Most people do not have this luxury, she said. But they actually need this vaccination urgently.

Rabies is one of the diseases on the World Health Organizations (WHO) list of NTDs. These diseases are most common in tropical regions, where access to health care or water and sanitation is often poor in global comparison.

There are solutions to some of these diseases readily available, but NTDs are not prioritized globally. And while some pharmaceutical companies have donated treatments and worked to tackle these diseases, there is minimal research and development being conducted on NTDs as there is no market for the drugs.

There is no effective drug against rabies. There is a vaccine, but it requires three doses per person, which can be difficult to deliver in areas with little access to health care.

Related Stories

More than 59,000 people die every year worldwide from this NTD, with 95% of human cases occurring in Africa and Asia, according to the WHO.

"With the polio [vaccine], it is only three drops to swallow. Here in Ghana, polio workers go from door to door to distribute the vaccine to every child under 5 years of age. I have a little daughter who has just had this done,"Binger explained. "But, unfortunately, there is no such simple vaccine against rabies for humans."

What makes it all the more tragic is that more than 40% of the rabies cases affect children under 15 and most of them are caused by a dog bite, Tasiame added.

Diagnosing rabies is also a challenge as there are no efficient or cost-effective rapid tests available. This means that doctors have to find alternative methods to confirm if a child has been bitten and infected by an animal.

"Children often say that they didn't tease the dog so that they don't get into trouble it just happened that he bit out of the blue. But that makes it difficult for us to find out whether the dog had rabies or not," Tasiame said. "The only thing us vets can do is go to the village and find the dog then I can know for certain whether it was a sick dog or not."

Theoretically, it is possible to administer a post-bite vaccine to prevent death from rabies.

"This does not work very well in Ghana. As a doctor, you have to know that the patient actually has rabies. You have to be able to obtain the vaccine because it is usually only available in the capital, Accra, but the cases occur far away, in the very north of Ghana, more than 13 hours by car," Binger said.

It is also impossible to vaccinate all children that have received a dog bite as the vaccine is far too expensive.

That is why attempts are being made to instead vaccinate the disease vectors in Ghana, this generally means dogs.

Related Stories

"The primary solution to rabies is to vaccinate as many dogs as possible,"Tasiame said.

The vaccine for dogs costs about $1.75 per vaccination, which is significantly cheaper than the one for humans, which costs around $105.

"In Ghana, the method is particularly useful because there are hardly any street dogs here every dog has an owner. We just have to get hold of the dogs and raise enough money to vaccinate enough dogs,:Tasiame said.

The government of Ghana has not done much to address this health crisis, according to Tasiame. The vet says that the last government-initiated vaccination campaign against rabies in Ghana took place in the 1970s.

Last year, Tasiame launched a vaccination campaign to educate about the disease and vaccinate dogs free of charge.

"The people who are most exposed to rabies infection are poor people. The area where I started the campaign is in the north of Ghana, a poor area. I went there for the first time last year. It feels like driving to the end of the world. The roads are bad, water and electricity supplies, and health care are a problem," Tasiame said. "Last year, we vaccinated 650 dogs, but that is not enough. Statistics show that we have 1.4 million dogs in Ghana."

About 70% of the dogs would have to be vaccinated to provide sufficient protection and this would need to be done every year.

Related Stories

"This year, we have collected enough money to vaccinate about 1,000 dogs most of it comes from friends," Tasiame said, adding that him and his team have also launched a small appeal and set up a function that allows people to donate via SMS.

Through word of mouth, Tasiame and his team encourage dog owners to bring their dogs for vaccination on World Rabies Day. The campaign takes place in a well-known place in the village so that its easy for everyone to find.

Tasiame's wish is for the world to see the issue and take action on it.

"Most people who die of rabies live in rural areas they have no education, no water, no road network,"he said. "And they still have to die of a disease that could be prevented with vaccines. That hurts me the most."

Go here to read the rest:
This Preventable Disease Kills Tens of Thousands of Children Every Year - globalcitizen.org

Watch here: https://www.youtube.com/watch?feature=youtu.be&v=VVkQU91KbEs

press release: The UW has a long history of pioneering medical advancements that have transformed the world. From performing the first bone marrow transplant in the United States to cultivating the first laboratory-derived human embryonic stem cells. Now, where will UW medical research go next?

On the next Wisconsin Medicine Livestream, meet trailblazing doctors, researchers, and medical leaders who are charting a bold course to completely alter the health care landscape. During this insightful panel discussion, well explore how gene therapy and cell replacements could hold the keys to treating inherited and acquired blindness. Youll also discover the remarkable potential in xenotransplantation where nonhuman animal source organs are transplanted into human recipients. In addition, you will learn about UW Healths journey to build a multidisciplinary program to serve the community. These, and other, fascinating developments in treatment and care are happening right now at the UW and are the future of medicine. The presentation will be moderated by Robert Golden, the dean of the University of WisconsinMadisons School of Medicine and Public Health.

Our Guests:

David Gamm, professor, Department of Ophthalmology and Visual Sciences; Emmett A. Humble Distinguished Director, McPherson Eye Research Institute; Sandra Lemke Trout Chair in Eye Research

Dr. Gamms lab is at the forefront in developing cell-based therapies to combat retinal degenerative diseases (RDDs). As the director of the McPherson Eye Research Institute and a member of the Waisman Center Stem Cell Research Program, the UW Stem Cell and Regenerative Medicine Center, and the American Society for Clinical Investigation, his efforts are directed toward basic and translational retinal stem cell research. The Gamm Lab uses induced pluripotent stem cells to create retinal tissues composed of authentic human photoreceptor cells rods and cones that can detect light and initiate visual signals in a dish. The aims of his laboratory are to investigate the cellular and molecular events that occur during human retinal development and to generate cells for use in retinal disease modeling and cell replacement therapies. In collaboration with other researchers at UWMadison and around the world, the lab is developing methods to produce and transplant photoreceptors and/or retinal pigment epithelium (RPE) in preparation for future clinical trials. At the same time, the Gamm Lab uses lab-grown photoreceptor and RPE cells to test and advance a host of other experimental treatments, including gene therapies. In so doing, the lab seeks to delay or reverse the effects of blinding disorders, such as retinitis pigmentosa and age-related macular degeneration, and to develop or codevelop effective interventions for these RDDs at all stages of disease.

Dhanansayan Shanmuganayagam, assistant professor, Department of Surgery, School of Medicine and Public Health; Department of Animal and Dairy Sciences, UWMadison; director, Biomedical, and Genomic Research Group

Dr. Shanmuganayagams research focuses on the development and utilization of pigs as homologous models to close the translational gap in human disease research, taking advantage of the overwhelming similarities between pigs and humans in terms of genetics, anatomy, physiology, and immunology. He and his colleagues created the human-sized Wisconsin Miniature Swine breed that is unique to the university. The breed exhibits greater physiological similarity to humans, particularly in vascular biology and in modeling metabolic disorders and obesity. He currently leads genetic engineering of swine at the UW. His team has created more than 15 genetic porcine models including several of pediatric genetic cancer-predisposition disorders such as neurofibromatosis type 1 (NF1). In the context of NF1, his lab is studying the role of alternative splicing of the nf1 gene on the tissue-specific function of neurofibromin and whether gene therapy to modulate the regulation of this splicing can be used as a viable treatment strategy for children with the disorder.

Dr. Shanmuganayagam is also currently leading the efforts to establish the University of Wisconsin Center for Biomedical Swine Research and Innovation (CBSRI) that will leverage the translatability of research in pig models and UWMadisons unique swine and biomedical research infrastructure, resources, and expertise to conduct innovative basic and translational research on human diseases. The central mission of CBSRI is to innovate and accelerate the discovery and development of clinically relevant therapies and technologies. The center will also serve to innovate graduate and medical training. As the only center of its kind in the United States, CBSRI will make UWMadison a hub of translational research and industry-partnered biomedical innovation.

Petros Anagnostopoulos, surgeon in chief, American Family Childrens Hospital; chief, Section of Pediatric Cardiothoracic Surgery; professor, Department of Surgery, Division of Cardiothoracic Surgery

Dr. Anagnostopoulos is certified by the American Board of Thoracic Surgery and the American Board of Surgery. He completed two fellowships, one in cardiothoracic surgery at the University of Pittsburgh School of Medicine and a second in pediatric cardiac surgery at the University of California, San Francisco School of Medicine. He completed his general surgery residency at Henry Ford Hospital in Detroit. Dr. Anagnostopoulos received his MD from the University of Athens Medical School, Greece. His clinical interests include pediatric congenital heart surgery and minimally invasive heart surgery.

Dr. Anagnostopoulos specializes in complex neonatal and infant cardiac reconstructive surgery, pediatric heart surgery, adult congenital cardiac surgery, single ventricle palliation, extracorporeal life support, extracorporeal membrane oxygenation, ventricular assist devices, minimally invasive cardiac surgery, hybrid surgical-catheterization cardiac surgery, off-pump cardiac surgery, complex mitral and tricuspid valve repair, aortic root surgery, tetralogy of Fallot, coronary artery anomalies, Ross operations, obstructive cardiomyopathy, and heart transplantation.

When: Tuesday, Sept. 29, at 7 p.m. CDT

Where: Wisconsin Medicine Livestream: wiscmedicine.org/programs/ending-alzheimers

See the original post:
ONLINE: The Future of Medicine - Isthmus